Mijares A, Malécot C O, Peineau N, Argibay J A
Physiologie des Cellules Cardiaques et Vasculaires, CNRS UMR 6542, Faculté des Sciences, Parc de Grandmont, Tours, 37200, France.
J Mol Cell Cardiol. 1997 Aug;29(8):2067-76. doi: 10.1006/jmcc.1997.0441.
Cyclosporin A (CsA), an immunosuppressive agent used to reduce rejection after organ transplantation, induces secondary effects in heart tissue. We have studied the effects in vivo and in vitro of CsA on L-type Ca2+ current (ICa) and the associated gating currents of isolated guinea-pig ventricular myocytes using the whole-cell patch-clamp technique. For in vivo experiments, a group of animals (n=28) was treated for 21 days by subcutaneous injection of CsA (15 mg/kg/day). Blood level of CsA was 1191+/-221 ng/ml (n=9). In cells from these animals (n=65, 19 animals), ICa was reduced to about 75% of that recorded from control cells (n=32, six animals). CsA decreased the availability of Ca2+ channels at potentials more positive than +30 mV. Isoproterenol (100 nM) was still able to increase ICa but only by 30+/-6% (n=9), whereas in control it increased ICa by 290+/-22% (n=5). Gating currents related to L-type Ca2+ channels were not altered in cells from CsA-treated animals. In in vitro experiments, CsA reduced ICa when applied directly to cardiomyocytes. CsA affected the kinetics of ICa inactivation, slowing down the rapid phase and accelerating the slow phase (n=4). The steady-state inactivation curve of ICa was shifted to more negative voltages and the degree of availability at -80 mV decreased by in vitro application of CsA. The half inactivation potential (V1/2) changed from -23+/-0.6 mV in control to -31+/-2 mV, -48+/-0.6 mV and -49+/-0.6 mV, in 1, 50 and 80 microM CsA, respectively. In these cells, the gating currents related to L-type Ca2+ channels were also not altered by CsA. CsA does not modify the Ca2+ channel density, although it induces a decrease in the beta1-adrenergic stimulation of ICa. The results are explained by a direct effect on the calcium channel inactivation of CsA and a non specific indirect effect.
环孢素A(CsA)是一种用于减少器官移植后排斥反应的免疫抑制剂,可在心脏组织中引发继发性效应。我们运用全细胞膜片钳技术,研究了CsA在体内和体外对分离的豚鼠心室肌细胞L型钙电流(ICa)及相关门控电流的影响。对于体内实验,一组动物(n = 28)通过皮下注射CsA(15毫克/千克/天)进行为期21天的治疗。CsA的血药浓度为1191±221纳克/毫升(n = 9)。在这些动物的细胞中(n = 65,19只动物),ICa降至对照细胞(n = 32,6只动物)记录值的约75%。CsA使电位高于+30毫伏时钙通道的可用性降低。异丙肾上腺素(100纳摩尔)仍能增加ICa,但仅增加30±6%(n = 9),而在对照中可使ICa增加290±22%(n = 5)。与L型钙通道相关的门控电流在CsA处理动物的细胞中未发生改变。在体外实验中,直接应用于心肌细胞时,CsA可降低ICa。CsA影响ICa失活的动力学,减慢快速相并加速慢速相(n = 4)。体外应用CsA使ICa的稳态失活曲线向更负的电压偏移,且在 - 80毫伏时的可用性程度降低。半失活电位(V1/2)在对照中为 - 23±0.6毫伏,在1、50和80微摩尔/升的CsA中分别变为 - 31±2毫伏、 - 48±0.6毫伏和 - 49±0.6毫伏。在这些细胞中,与L型钙通道相关的门控电流也未被CsA改变。CsA虽诱导ICa的β1 - 肾上腺素能刺激减少,但不改变钙通道密度。这些结果可通过CsA对钙通道失活的直接作用和非特异性间接作用来解释。